New Joint Commission standards change scoring and eliminate FMEAs
Ambulatory Quality and Compliance Insider, September 1, 2008
This is an excerpt from a member only article. To read the article in its entirety, please login.
Surgery centers accredited by The Joint Commission will face two seismic changes come January 1, 2009. The new standards will no longer require surgery centers to conduct Failure Modes and Effects Analysis (FMEA), and the scoring process will now factor in the severity of violations.
And if noncompliance with even one standard poses an imminent risk of patient death, the surgery center could face an expedited preliminary denial of accreditation.
“They have a priority tier,” says Jan Allison, RN, director of quality and accreditation at Surgical Care Affiliates in Birmingham, AL, who serves on the ASC Advisory Task Force for The Joint Commission and took part in calls on the Standards Improvement Initiative (SII).
This is an excerpt from a member only article. To read the article in its entirety, please login.
Comments
0 comments on “New Joint Commission standards change scoring and eliminate FMEAs ”
Related Products
Most Popular
- Articles
-
- Featured blog post: Nurses face felony charges after reporting physician to the Texas Medical Board
- HIPAA Q&A: TPO disclosures to a business associate
- Q/A: Coding infusions to correct low potassium levels
- Topic: CMS, OESS post new security compliance review information, checklist
- What does case-mix index mean to you?
- The debate continues: Nurses who reported physician to the Texas Medical Board file federal appeal
- State medical board will hear unprofessional charges against OB-GYN
- Capturing all necessary codes for IUD insertion and removal can be challenging
- QA:Coding multiple initial infusions
- Major mobile operators to support free text alerts
- E-mailed
-
- Featured blog post: Nurses face felony charges after reporting physician to the Texas Medical Board
- Q/A: Coding infusions to correct low potassium levels
- Know criteria for coverage when podiatrists use Dermagraft® tissue substitute
- Note: Clarification of reference (non-patient) laboratory testing
- HIPAA Q&A: TPO disclosures to a business associate
- Get the facts on coding for non-biodegradeable drug delivery implants
- Facility E/M Levels, 2009 OPPS
- Do not separately report defibrillation
- Defining 'integral' for self-administered drugs is challenging
- Consider the big picture before querying physicians
- Searched
